)
Freemelt (FREEM) investor relations material
Freemelt Investor update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic update and business expansion
Strategy expanded to include manufacturing qualified parts for end customers, moving beyond 3D printer sales and addressing demand for serial production and resilient supply chains.
Two business areas established: equipment/production system sales (e.g., MedTech) and qualified part manufacturing for sectors like fusion and defense.
Leveraging E-PBF technology, expertise in extreme materials, and established customer relationships to support both in-house and outsourced manufacturing needs.
New business area launched with a major order from Fusion for Energy, linked to the ITER project, highlighting demand for qualified manufacturing in advanced sectors.
Company aims to emulate advanced manufacturing models seen in China, targeting critical applications and manufacturing resilience in Europe.
Market opportunity and financial ambitions
Addressable market opportunity expanded to SEK 450–560 billion for manufacturing and assembly, compared to SEK 20–30 billion for equipment sales.
Recent order involves producing 31,000 tungsten tiles and monoblocks over 22 months, valued at SEK 55–84 million.
Approach is equity-light, leveraging partnerships, scalable external capacity, and asset financing tied to contracts to minimize capital investment.
Financial targets reaffirmed: SEK 1 billion annual order intake by 2030 and EBITDA positive by 2028.
Expecting more than half of revenues to come from recurring sources such as services, aftermarket, and long-term customer relationships.
Operational outlook and risk assessment
Key KPIs include order intake, order book health, and business mix.
Technology proven with 45 systems sold and over 40 qualification projects completed in two years.
Main risk identified as geopolitical competition, with urgency for Europe to establish manufacturing resilience.
Vision to become an industrial platform for extreme materials and critical applications in Europe, supporting customers from technology adoption to industrial deployment.
Organic growth prioritized, with selective acquisitions considered to complement the industrial platform.
- Order intake rose and cash flow turned positive despite lower sales, driven by new strategic deals.FREEM
Q2 2026 - Record sales, fusion breakthroughs, and China entry drive growth in AM and medtech.FREEM
Investor Update - Scaling up with 162% revenue growth, new funding, and global expansion in MedTech, defense, and fusion.FREEM
Investor update - Q1 net sales rose 116% YoY, with strong margins and key sector collaborations advancing.FREEM
Q1 2026 - Sales up 172% to SEK 54.5m, installed base up 40%, and strong growth in key sectors.FREEM
Q4 2025 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days - Q2 saw high activity, new orders, and strategic partnerships despite a wider loss.FREEM
Q2 2024 - First industrial eMELT sale, OEM order, and machine sales growth amid ongoing losses.FREEM
Q3 2024 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 2024
Next Freemelt earnings date
Next Freemelt earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage